Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human DYRK2 Stable Cell Line

    [CAT#: S01YF-1123-KX219]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1106 Magic™ Human DYRK2 in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    DYRK2
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Reproductive Research
    Related Diseases
    Intellectual Developmental Disorder, Autosomal Dominant 7. Among its related pathways are Gene expression (Transcription) and Regulation of TP53 Activity
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The DYRK2 gene in humans codes for the enzyme dual-specificity tyrosine-phosphorylation-regulated kinase 2, or more specifically, dual-specificity kinase. As a member of a family of protein kinases, DYRK2 is likely involved in the growth and development of cells. The ability of the family to autophosphorylate on tyrosine residues and the structural similarities of their kinase domains characterize them. In vitro tyrosine autophosphorylation and catalyzed phosphorylation of histones H3 and H2B have been demonstrated by DYRK2. DYRK2 has been found to have two isoforms. There is no 5' terminal insert in isoform 1, which is the major isoform. The customized DYRK2 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Nancy

    The DYRK2 cell line worked as advertised and was a cost-effective alternative in our studies. We obtained consistent results, and the cell line showed good stability over extended periods. Mar 07 2020

    chat Verified Customer

    chat Jessica

    The DYRK2 cell line worked flawlessly, and the detailed protocols provided by the company made the whole process much easier. Nov 07 2020

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 NOTCH1 protein levels are modulated by DYRK2.

    After transfecting HEK-293T cells with the designated plasmids, the cells were lysed 48 hours later. Immunoblotting was used to assess the expression of proteins.

    Ref: Morrugares, Rosario, et al. "Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2." Cellular and Molecular Life Sciences 77 (2020): 2621-2639.

    Pubmed: 31605148

    DOI: 10.1007/s00018-019-03309-9

    Research Highlights

    From yeast to mammals, dual-specificity tyrosine-regulated kinases (DYRKs) have been conserved throughout evolution. A growing body of research has demonstrated the significance of DYRKs in survival and cell cycle regulation.
    Yoshida, Saishu, and Kiyotsugu Yoshida. "Multiple functions of DYRK2 in cancer and tissue development." FEBS letters 593.21 (2019): 2953-2965.
    Pubmed: 31505048   DOI: 10.1002/1873-3468.13601

    These findings demonstrated that DYRK2 expression in HCC tumor tissues was downregulated, which may have encouraged the growth of HCC cells. Furthermore, in HCC, decreased DYRK2 expression was linked to a poor prognosis and oxaliplatin resistance.
    Zhang, Xiubing, et al. "Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma." Pathology-Research and Practice 212.3 (2016): 162-170.
    Pubmed: 26804244   DOI: 10.1016/j.prp.2016.01.002

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare